Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R19 - Effective July 2, 2024

Date Posted: February 5, 2026

This Billing and Coding Article has been revised under contract numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: July 2, 2024

Summary of Changes:

Under Article Text revised Table 2 APOE row to add donanemab. This revision is due to FDA guidelines and is effective 7/2/2024.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )